Black Hawk Acquisition holds extraordinary general meeting; 77.3% of shares represented
Black Hawk Acquisition Corporation held an extraordinary general meeting on October 13, 2026. Shareholders authorized the business combination agreement with Vesicor Therapeutics and BH Merger Sub, covering the related transactions. Investors also backed a domestication to Delaware; the vote did not confirm completion